logo
Select company
Select metric
0.74Cash Ratio
VS
Market
60
Sector
34
Industry
20
History
43
$ 2.37Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 17.89M0.74$ 24.09M
3/31/2025$ 19.46M0.8$ 24.32M
12/31/2024$ 19.76M0.77$ 25.62M
9/30/2024$ 27.41M1.13$ 24.22M
6/30/2024$ 23.4M0.4$ 57.97M
3/31/2024$ 27.21M0.5$ 54.83M
12/31/2023$ 23.63M0.52$ 45.53M
9/30/2023$ 20.41M0.47$ 43.36M
6/30/2023$ 48.18M2.09$ 23.11M
3/31/2023$ 33.04M1.05$ 31.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 0.31.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average Cash Ratio has been 0.64.
  • The median Cash Ratio for PROTALIX BIOTHERAPEUTICS INC during this period was 0.49
  • PROTALIX BIOTHERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 2.09.
  • The lowest Cash Ratio recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 0.21

PROTALIX BIOTHERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
CSBR : CHAMPIONS ONCOLOGY INC 0.45THTX : THERATECHNOLOGIES INC 0.24BDTX : BLACK DIAMOND THERAPEUTICS INC 1.83SPRO : SPERO THERAPEUTICS INC 2.09ENTA : ENANTA PHARMACEUTICALS INC 1.01CELU : CELULARITY INC 0.16IVVD : INVIVYD INC 0.79DOMH : DOMINARI HOLDINGS INC 0.57SGMO : SANGAMO THERAPEUTICS INC 0.84ALEC : ALECTOR INC 0.55

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: CashnEq [ $ 13.53M ] / LiabilitesC [ $ 43.9M ]
(=) Cash Ratio [ 0.31 ]

PLX - Cash Ratio, Last 5 years

0.21

Minimum

Dec 31, 2020

2.09

Maximum

Jun 30, 2023

0.64

Average

0.49

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63